lopinavir has been researched along with Hyperlipemia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HJ; Colletti, L; Degoey, DA; Dekhtyar, T; Flentge, CA; Flosi, WJ; Grampovnik, DJ; Kati, WM; Kempf, DJ; Klein, LL; Mamo, M; Marsh, KC; Mo, H; Molla, A; Morfitt, DC; Nguyen, B; Randolph, JT; Schmidt, JM; Stoll, V; Swanson, SJ; Yeung, CM | 1 |
| Alghazwani, Y; Asiri, YI; Durgaramani, S; Kalpana, K; Krishnaraju, V; Kumar, V; Noohu, AK; Prabahar, K; Premalatha, P; Rajalakshimi, V; Sirajudeen, SA; Vinoth Prabhu, V | 1 |
| Aga, E; Bartlett, J; Hosseinipour, MC; Hughes, MD; Kumarasamy, N; Matoga, MM; Ribaudo, HJ | 1 |
| Ananworanich, J; Boonrak, P; Bunupuradah, T; Burger, D; Engchanil, C; Intasan, J; Kosalaraksa, P; Lumbiganon, P; Ruxrungtham, K; Schutz, M | 1 |
| Curran, A; Ribera Pascuet, E | 1 |
| Cohen, CJ; Greenblatt, DJ; Hellinger, JA; Rhee, MS; Sheble-Hall, S | 1 |
| Cao, R; Gurley, EC; Hu, Y; Hylemon, PB; Pandak, WM; Sanyal, AJ; Studer, EJ; Wang, X; Wang, Y; Zhang, L; Zhou, H | 1 |
| Bruce-Keller, AJ; Gupta, S; Ingram, DK; Keller, JN; Knight, AG; Losso, BY | 1 |
| Badiou, S; Baillat, V; Cristol, JP; De Boever, CM; Dupuy, AM; Reynes, J | 1 |
| Calza, L; Chiodo, F; Farneti, B; Manfredi, R | 1 |
| Esteban, A; Gutiérrez, F; Hernández, I; Martin-Hidalgo, A; Masiá, M; Navarro, A; Padilla, S; Ramos, J | 1 |
| Gutiérrez, F; Hernández, I; Masiá, M; Navarro, A; Padilla, S | 1 |
| Antela, A; Arribas, JR; Barros, C; Berenguer, J; Cepeda, C; Condes, E; Dronda, F; González-García, JJ; Miralles, P; Montes, ML; Navas, E; Peña, JM; Pérez, S; Pulido, F; Rubio, R; Sanz, J; Vázquez, JJ; Zapata, A | 1 |
| Cua, E; Dellamonica, P; Dunais, B; Fontas, E; Garraffo, R; Lavrut, T; Pradier, C; Valerio, L | 1 |
| Mashinter, LD; Roberts, SE; Shafran, SD | 1 |
| Adorni, F; Biasi, P; Bini, T; Bongiovanni, M; Chiesa, E; Cicconi, P; Di Biagio, A; Landonio, S; Meraviglia, P; Monforte, AD; Testa, L; Tordato, F | 1 |
6 trial(s) available for lopinavir and Hyperlipemia
| Article | Year |
|---|---|
Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.
Topics: Anti-HIV Agents; Blood Chemical Analysis; CD4 Lymphocyte Count; Child; Cholesterol; Drug Resistance, Viral; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lopinavir; Male; Prospective Studies; Pyrimidinones; Ritonavir; Saquinavir; Thailand; Treatment Refusal; Triglycerides; Viral Load | 2008 |
[Darunavir as first-line therapy. The TITAN study].
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Darunavir; Diarrhea; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lopinavir; Male; Prognosis; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Salvage Therapy; Sulfonamides | 2008 |
Incidence of hyperlipidaemia in a cohort of 212 HIV-infected patients receiving a protease inhibitor-based antiretroviral therapy.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cholesterol; Cholesterol, LDL; Cohort Studies; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lopinavir; Male; Prospective Studies; Pyrimidinones; Ritonavir; Triglycerides | 2003 |
Lopinavir plasma concentrations and changes in lipid levels during salvage therapy with lopinavir/ritonavir-containing regimens.
Topics: Adult; Cholesterol; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lipid Metabolism; Lipids; Lopinavir; Male; Prospective Studies; Pyrimidinones; Ritonavir; Time Factors; Triglycerides | 2003 |
Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Cholesterol, HDL; Cholesterol, LDL; Female; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Lipids; Lopinavir; Male; Middle Aged; Pyrimidinones; Risk Factors; Ritonavir; Triglycerides | 2005 |
The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Fasting; Female; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; Triglycerides | 2005 |
10 other study(ies) available for lopinavir and Hyperlipemia
| Article | Year |
|---|---|
2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.
Topics: Animals; Binding Sites; Biological Availability; Caco-2 Cells; Carbamates; Cell Membrane Permeability; Crystallography, X-Ray; Dipeptides; Dogs; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Hyperbilirubinemia; Hyperlipidemias; In Vitro Techniques; Microsomes, Liver; Models, Molecular; Mutation; Putrescine; Pyridines; Rats; Rats, Gunn; Stereoisomerism; Structure-Activity Relationship | 2009 |
Beneficial effects of Naringin against lopinavir/ ritonavir-induced hyperlipidemia and reproductive toxicity in male albino rats.
Topics: Animals; Cholesterol, LDL; Hyperlipidemias; Lipids; Lopinavir; Male; Rats; Ritonavir; Triglycerides | 2023 |
Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings.
Topics: Adolescent; Adult; Aged; Biomarkers; CD4 Lymphocyte Count; Clinical Trials as Topic; Developing Countries; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Incidence; Lipids; Lopinavir; Male; Middle Aged; Multicenter Studies as Topic; Risk Factors; Ritonavir; Viral Load; Young Adult | 2017 |
Relationship between plasma protease inhibitor concentrations and lipid elevations in HIV patients on a double-boosted protease inhibitor regimen (saquinavir/lopinavir/ritonavir).
Topics: Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lipids; Lopinavir; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrimidinones; Retrospective Studies; Ritonavir; Saquinavir | 2010 |
Prevention of HIV protease inhibitor-induced dysregulation of hepatic lipid metabolism by raltegravir via endoplasmic reticulum stress signaling pathways.
Topics: Animals; Apoptosis; Cells, Cultured; Drug Antagonism; Endoplasmic Reticulum; Hepatocytes; HIV Integrase Inhibitors; HIV Protease Inhibitors; Hyperlipidemias; Lipid Metabolism; Liver; Lopinavir; Male; Mice; Mice, Inbred C57BL; Pyrimidinones; Pyrrolidinones; Raltegravir Potassium; Rats; Ritonavir; Signal Transduction | 2010 |
Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance.
Topics: Animals; Brain Injuries; Cerebral Cortex; Hippocampus; HIV Protease Inhibitors; Hyperlipidemias; Insulin Resistance; Lipodystrophy; Lopinavir; Male; Mice; Mice, Inbred C57BL; Ritonavir | 2012 |
Small dense LDL and atherogenic lipid profile in HIV-positive adults: influence of lopinavir/ritonavir-containing regimen.
Topics: Adult; Antiretroviral Therapy, Highly Active; Arteriosclerosis; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lipids; Lipoproteins, LDL; Lopinavir; Pyrimidinones; Ritonavir | 2003 |
Lipid abnormalities in HIV-Infected patients and lopinavir plasma concentrations.
Topics: Anti-HIV Agents; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperlipidemias; Lipids; Lopinavir; Prospective Studies; Pyrimidinones; Ritonavir | 2004 |
Lopinavir/ritonavir combination and total/HDL cholesterol ratio.
Topics: Adult; Cholesterol; Cholesterol, HDL; Drug Combinations; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lopinavir; Male; Middle Aged; Pyrimidinones; Retrospective Studies; Ritonavir; Time Factors | 2005 |
Predictive factors of hyperlipidemia in HIV-infected subjects receiving lopinavir/ritonavir.
Topics: Adult; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir | 2006 |